Evento S-GE Fattori chiave di successo per fare affari in Giappone 23 abr 2024 10:15–12:10 Zürich Suíça
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 abr 2024 10:15–12:10 Zürich Suíça
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23 abr 2024 10:15–12:10 Zürich Suíça
News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Actualités 17 abr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 19 dez 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Actualités 14 ago 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
News 17 abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 10 mai 2022 Michael J. Fox Foundation awards Asceneuron a grant to treat Parkinson’s disease Committed to accelerating research into novel Parkinson’s Disease therapies, The Michael J. Fox Foundation for Parkinson’s Research is again awar...